Infection-driven proliferative phase impairment in chronic wounds: a mechanistic framework for precision regenerative therapy - Takeaways - MDSpire

Infection-driven proliferative phase impairment in chronic wounds: a mechanistic framework for precision regenerative therapy

  • By

  • Qingmei Yang

  • Chuyu Liu

  • Qi Wang

  • Jing An

  • Yulan Cai

  • May 14, 2026

Share

  • 1

    Chronic wounds fail to heal due to infection-driven impairment of the proliferative phase, disrupting cellular expansion and tissue repair.

  • 2

    Wound-associated microbial communities establish pathogenic ecosystems that compromise host regenerative programs through virulence factors and biofilm persistence.

  • 3

    The proposed IDPPI framework reorders causality, emphasizing infection-driven blockade of proliferative repair as a primary failure mode in chronic wounds.

  • 4

    Targeted therapeutic strategies should focus on suppressing microbial virulence, restoring immune homeostasis, and promoting regeneration using advanced materials.

  • 5

    Advancements in multi-omics, biomimetic models, and real-time technologies can enable dynamic assessment and adaptive interventions in chronic wound management.

Original Source(s)

Infection-driven proliferative phase impairment in chronic wounds: a mechanistic framework for precision regenerative therapy

  • by Qingmei Yang, Chuyu Liu, Qi Wang, Jing An, Yulan Cai

  • May 14, 2026

Related Content

CAP Antibiotics May Not Benefit Nonsevere COVID-19 Infections

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

FDA Clears AI Sepsis Warning System

An FDA-cleared AI tool developed at Johns Hopkins detects sepsis up to 48 hours earlier than clinicians — and has cut related deaths by 18%.